<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Change in BPI scores from baseline also did not differ significantly between the groups for those receiving any maintenance therapy versus no maintenance therapy (
 <italic>P</italic> = 0.81) and those receiving lenalidomide-only maintenance therapy versus no maintenance therapy (
 <italic>P</italic> = 0.42; Fig. 7a and b; Table 7 [Online Resource 
 <xref rid="MOESM1" ref-type="media">1</xref>]). BPI decreased significantly from pre-ASCT (analytic baseline) to follow-up for the groups receiving any maintenance therapy and lenalidomide-only maintenance therapy and significantly increased at progression for all groups (
 <italic>P</italic> &lt; 0.001; Fig. 7c [Online Resource 
 <xref rid="MOESM1" ref-type="media">1</xref>]).
</p>
